Combination of Immune Checkpoint Inhibitors with Chemotherapy in Lung Cancer
Wei Liu,1,2 Lei Zhang,1,2 Zhiming Xiu,2 Jian Guo,1 Liye Wang,3 Yue Zhou,4 Yang Jiao,1 Meiyan Sun,1 Jianhui Cai1,2 1College of Laboratory Medicine, Jilin Medical University, Jilin 132013, People’s Republic of China; 2Jilin Collaborative Innovation Center for Antibody Engineering, Jilin Medi...
Main Authors: | Liu W, Zhang L, Xiu Z, Guo J, Wang L, Zhou Y, Jiao Y, Sun M, Cai J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-07-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/combination-of-immune-checkpoint-inhibitors-with-chemotherapy-in-lung--peer-reviewed-article-OTT |
Similar Items
-
Can Immunogenic Chemotherapies Relieve Cancer Cell Resistance to Immune Checkpoint Inhibitors?
by: Thaiz Rivera Vargas, et al.
Published: (2019-05-01) -
Combining Immune Checkpoint Inhibitors with Anti-Angiogenic Agents
by: Paola Ciciola, et al.
Published: (2020-03-01) -
The Application of Combined Immune Checkpoint Inhibitor Modalities in Previously Treated Non-Small Cell Lung Cancer Patients and the Associations Thereof With the Lung Immune Prognostic Index
by: Ting Zhang, et al.
Published: (2021-06-01) -
Baseline Serum Cholesterol Levels Predict the Response of Patients with Advanced Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitor-Based Treatment
by: Tong III J, et al.
Published: (2021-05-01) -
Association of lymphocyte subsets with efficacy and prognosis of immune checkpoint inhibitor therapy in advanced non-small cell lung carcinoma: a retrospective study
by: Jia, J., et al.
Published: (2022)